KCL’s best PI has been promoted to Professor!

Professor Irshad delivered a fantastic inaugural talk titled “Encounters that endure”, she reflected on moments and relationships that influenced her journey as a clinician scientist from early lessons in care and compassion to the collaborations and discoveries that continue to shape her work.

Congratulations to Professor Richard Vile for his recent appointment as the Joan Reece Chair in Immuno-oncology!

The Joan Reece Immuno-oncology Research Programme will focus on advancing ground-breaking work in harnessing the body’s own defences to better understand and treast cancer. This appointment will accelerate the pioneering work done at King’s throughout the years, paving the way for more effective treatments aiming to provide better and gentler care to our cancer patients.

Dr Paul R. Buckley, Dr Helen Kakkassery and Thanussuyah Alaguthurai, three members of the Tumour Immunology Group at King’s College London, have been nominated to the Future Leaders Working Group of Cancer Grand Challenges. Representing Team SAMBAI, they will help shape the Future Leaders Programme, which nurtures the next generation of cancer researchers.

Congratulations to Helen Kakkassery, PhD student in our lab for wining first prize at the 2025 King’s College London School of Cancer and Pharmaceutical Sciences Postgraduate Symposium!

Cancer is a disease that affects every community however the treatment awareness and access is below average for many ethnic minority patients. As researchers it’s our responsibility to deliver healthcare to those in need.

Team SAMBAI, co-led by Dr. Sheeba Irshad from King’s College London, has been awarded major funding through Cancer Grand Challenges to address one of cancer research’s most urgent frontiers—equity